[HTML][HTML] Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis
P Krausewitz, A Borkowetz, G Ortner, K Kornienko… - World Journal of …, 2024 - Springer
Purpose The combined approach (CB) of magnetic resonance imaging (MRI)-guided biopsy
(TB) and systematic biopsy (SB) is strongly recommended based on numerous studies in …
(TB) and systematic biopsy (SB) is strongly recommended based on numerous studies in …
Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA?
F Giganti, RT Gupta - American Journal of Roentgenology, 2024 - Am Roentgen Ray Soc
In this cost-effectiveness study [1], the authors utilize a decision analytic Markov model,
incorporating current US epidemiologic and clinical data, to project costs and outcomes over …
incorporating current US epidemiologic and clinical data, to project costs and outcomes over …
Beyond the AJR: Biparametric MRI-Based Prostate Cancer Screening—A Cost-Effective Alternative to PSA Screening and Standard Biopsy
RD Ward, AS Purysko - American Journal of Roentgenology, 2023 - Am Roentgen Ray Soc
Commentary on Hao S, Discacciati A, Eklund M, et al. Cost-effectiveness of prostate cancer
screening using magnetic resonance imaging or standard biopsy based on the STHLM3 …
screening using magnetic resonance imaging or standard biopsy based on the STHLM3 …
The'Rapid Access Prostate Imaging and Diagnosis'(RAPID) diagnostic pathway: what is the rush?
J Lopez, RJ Bryant - BJU international, 2023 - search.ebscohost.com
With pre-biopsy multiparametric MRI (mpMRI) and new biopsy techniques, PCa diagnosis
has become more precise, simultaneously reducing under-detection of clinically significant …
has become more precise, simultaneously reducing under-detection of clinically significant …
[HTML][HTML] The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics—Real-world Evidence from 2018 to 2022
T Palsdottir, H Söderbäck, F Jäderling… - European Urology Open …, 2024 - Elsevier
Abstract Background The Capio Prostate Cancer Center (Capio PCC) in Stockholm,
Sweden, adopts a comprehensive diagnostic approach, utilizing prostate-specific antigen …
Sweden, adopts a comprehensive diagnostic approach, utilizing prostate-specific antigen …
Prostate-Specific Antigen Screening Should Not Be Covered by Publicly Funded Health Insurance—Reply
S Hao, T Nordström, MS Clements - JAMA oncology, 2023 - jamanetwork.com
In Reply We read with interest the letter by Takahashi in response to our economic
evaluation study. 1 We agree with the author—and with most commentators—that there is …
evaluation study. 1 We agree with the author—and with most commentators—that there is …
Survival Benefit and Cost Effectiveness of a Future Blood‐Based Diagnostic Test to Detect Cerebral Aneurysm Formation
AM Mittal, KW Nowicki, R Dembinski… - Stroke: Vascular and …, 2024 - Am Heart Assoc
Background Cerebral aneurysms are common, but there is no blood test for their diagnosis.
Cerebral aneurysms are diagnosed incidentally or upon rupture. Current diagnostic tools …
Cerebral aneurysms are diagnosed incidentally or upon rupture. Current diagnostic tools …
[HTML][HTML] Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe
P Vynckier, L Annemans, S Raes, C Amrouch… - European Urology, 2024 - Elsevier
Abstract Background and objective In Europe, prostate cancer (PCa) is the most common
cancer in men. Screening may therefore be crucial to lower health care costs, morbidity, and …
cancer in men. Screening may therefore be crucial to lower health care costs, morbidity, and …